Shopping Cart 0
Cart Subtotal
AED 0

23andMe Inc - Medical Equipment - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
AED 918

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
AED 1835

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
AED 2753
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Summary

23andMe Inc (23andMe) is a biotechnology research and information provider that offers tools for health and ancestry care. The company offers raw genetic data and ancestry-related genetic reports. Its service portfolio includes clinical development, research and development, ancestry services, commercialization services, and information of personal ancestry, genealogy and inherited traits. 23andMe's ancestry services comprise ancestry composition, family tree tool, DNA relatives, maternal and paternal lineages, and neanderthal percentage. The company helps individuals to understand their genetic information using DNA analysis technologies and web-based interactive tools. It serves students, clinicians, and developers. 23andMe is headquartered in Mountain View, California, the US.

23andMe Inc-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

23andMe Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5

23andMe Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6

23andMe Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7

23andMe Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8

23andMe Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9

23andMe Inc, Medical Equipment, Deal Details 10

Venture Financing 10

23andMe to Raise up to USD300 Million in Financing 10

23andMe Raises USD250 Million in Venture Financing 11

Freenome Raises Additional USD7 Million in Series A Financing 13

Partnerships 14

Lieber Institute for Brain Development (LIBD) Partners with 23andME 14

Acquisition 15

23andMe Acquires CureTogether 15

23andMe Inc-Key Competitors 16

23andMe Inc-Key Employees 17

23andMe Inc-Locations And Subsidiaries 18

Head Office 18

Recent Developments 19

Legal and Regulatory 19

Oct 31, 2018: 23andMe granted the first and only FDA Authorization for direct-to-consumer pharmacogenetic reports 19

Government and Public Interest 20

Jun 17, 2018: Breast cancer researcher warns against online genetic tests 20

Feb 20, 2018: At-Home Genetic Testing Leads to Misinterpretations of Results 22

Feb 22, 2017: Celmatix and 23andMe Announce Launch of Fertility Research Community 23

Product News 24

Apr 06, 2017: FDA allows marketing of first direct-to-consumer tests that provide genetic risk information for certain conditions 24

Other Significant Developments 26

Aug 28, 2018: 23andme turns off consumer access to porting their genetic data to Timidna, disappointing many consumers 26

Aug 21, 2018: Dash Genomics launches a personalized Alzheimer's Disease analysis using genetic data 27

May 03, 2017: 23andMe and German Pain Specialist Grunenthal Explore the Genetics of Pain to Help Identify New Treatments for Patients 28

Appendix 29

Methodology 29

About GlobalData 29

Contact Us 29

Disclaimer 29


List Of Figure

List of Figures

23andMe Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2

23andMe Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2

23andMe Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2

23andMe Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2

23andMe Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5

23andMe Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6

23andMe Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7

23andMe Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8


List Of Table

List of Tables

23andMe Inc, Medical Equipment, Key Facts 2

23andMe Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2

23andMe Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5

23andMe Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6

23andMe Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7

23andMe Inc, Deals By Market, 2012 to YTD 2018 8

23andMe Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9

23andMe to Raise up to USD300 Million in Financing 10

23andMe Raises USD250 Million in Venture Financing 11

Freenome Raises Additional USD7 Million in Series A Financing 13

Lieber Institute for Brain Development (LIBD) Partners with 23andME 14

23andMe Acquires CureTogether 15

23andMe Inc, Key Competitors 16

23andMe Inc, Key Employees 17

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

23andMe Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.